Cargando…
Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Drug resistance is a serious problem in the treatment of HCC. Therefore, it is of high clinical impact to discover targeted therapies that may overcome drug-related resistance and impro...
Autores principales: | Ragusa, Federica, Panera, Nadia, Cardarelli, Silvia, Scarsella, Marco, Bianchi, Marzia, Biagioni, Stefano, Giorgi, Mauro, Alisi, Anna, Massimi, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125776/ https://www.ncbi.nlm.nih.gov/pubmed/34062786 http://dx.doi.org/10.3390/cancers13092182 |
Ejemplares similares
-
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
por: Giorgi, Mauro, et al.
Publicado: (2020) -
Structural Characterization of Murine Phosphodiesterase 5 Isoforms and Involvement of Cysteine Residues in Supramolecular Assembly
por: Giorgi, Mauro, et al.
Publicado: (2023) -
Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms
por: Cardarelli, Silvia, et al.
Publicado: (2022) -
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
por: Massimi, Mara, et al.
Publicado: (2019) -
Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma
por: Panera, Nadia, et al.
Publicado: (2017)